ReachRxResearch
Home
Research
Sign Up
PQBP1-dependent alternative RNA splicing underlies high calorie diet-induced cognitive impairment
Back to Research Hub
  1. Home
  2. Research Hub
  3. PQBP1-dependent alternative RNA splicing…

PQBP1-dependent alternative RNA splicing underlies high calorie diet-induced cognitive impairment

Molecular Psychiatry·September 12Open Access
PsychiatryLimited evidenceAlzheimer'S DiseaseCognitive ImpairmentIntellectual DisabilityObesityAnimal StudyGene TherapyRNA Splicing ModulationAdult

Summary

View source

What was studied

This study investigated how a high calorie-high fat diet (HFD) causes cognitive impairment in mice, focusing on the role of PQBP1 (an RNA splicing factor) and downstream alternative splicing changes in synapse-related genes over 1 or 6 weeks of HFD exposure.

Key findings

HFD suppresses PPARγ-driven PQBP1 expression, leading to aberrant alternative splicing of synaptic genes (CASK, Cacnb1, Cyfip2, Syt1) that impairs presynaptic vesicle release; AAV-mediated restoration of PQBP1, CASK, Cacnb1, Cyfip2, or Syt1 rescued synaptic and cognitive deficits in HFD mice.

Study limitations

Findings are based entirely on mouse models (HFD-fed and PQBP1-cKO); direct human translational evidence is absent. The study does not quantify the degree or reversibility of cognitive impairment with dietary intervention alone. Mechanistic rescue used AAV gene delivery, which is not clinically available for this indication.

Clinical implications

While not yet clinically actionable, this work identifies a PPARγ–PQBP1–presynapse axis as a potential therapeutic target linking high-fat diet to cognitive decline. Clinicians counseling patients on dementia risk should continue to emphasize dietary modification, as this study provides molecular support for HFD as a pathological brain modifier.

Caveats

  • PQBP1 is noted as implicated in both intellectual disability and Alzheimer's disease, but this study does not directly model Alzheimer's disease pathology — the AD connection is contextual background.
  • Sample sizes for individual experiments are not reported in the abstract; level of evidence rating reflects preclinical animal study design.
  • Study is entirely preclinical (mouse models); no human subjects or clinical data are included. Generalizability to human HFD-related cognitive impairment is inferential.

Related Questions

Explore related topics

What is the evidence linking high-fat diet to dementia risk and cognitive decline?How does PPARγ activation affect neurodegeneration and Alzheimer's disease pathology?What are the current therapeutic strategies targeting RNA splicing in neurological disorders?

Publication Details

Year
2026
Journal
Molecular Psychiatry
Source
View article
Keep scrolling
More content below.
Up Next